Researchmoz added Most up-to-date research on "Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis" to its huge collection of research reports.
Adult Vaccines Market is expected to be close to US$ 20 Billion by the year 2022. Because of vaccines, some diseases (like Polio and Diphtheria) are becoming rare. Vaccination can prevent certain deadly diseases in all age groups. Almost all countries around the world have introduced efficient National Immunization Programme in their vaccination schedule to overcome the epidemics caused by vaccine-preventable diseases. WHO’s Global Vaccine Action Plan, Global Immunization Vision and Strategy (GIVS), The GAVI Alliance all are putting their best to minimize the incidence of vaccine-preventable diseases which indeed is driving the adult vaccine market vigorously.
For more info, Get Free PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=1237587
Influenza Vaccine Leads the Adult Vaccine Market for the Year 2017
Influenza vaccine is dominating the adult vaccine segment in year 2017, however it will lose its place to Pneumococcal vaccine in the coming future as admissions for pneumonia had almost tripled over the last 15 years. Other than Influenza and Pneumococcal Vaccines, Cervical Cancer (HPV), Hepatitis and Travel vaccines also have considerable market share in adult vaccines market.
Considerable Growth in Immunization of Cervical Cancer (HPV), Zoster, Meningococcal, Hepatitis, Tdap and MMRV Vaccines
In terms of Immunization; Influenza holds the maximum share as influenza vaccination is recommended to take annually in almost all countries of the world. However, with the growing awareness and efficiency of vaccines in preventing diseases, our analysis found that there will be considerably growth in the number for people opting for Cervical Cancer (HPV), Zoster, Meningococcal, Hepatitis, Tdap and MMRV vaccines in future till 2022.
Administration of Vaccines Doses
Influenza Vaccine holds the topmost place while talking about the administration of vaccine doses as influenza strains change every year and people needs to get an updated influenza shot each year to stay protected. Expect Influenza; Cervical Cancer (HPV), Pneumococcal and Hepatitis vaccines have remarkable administration doses.
Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis is the 2nd publication by Renub Research on Adult Vaccines Market. This 181 pages research report with 77 Figures and 32 Tables provides a complete analysis of Adult Vaccines Market, Immunization Numbers in People, Number of Vaccine Doses Administered in Adults (Disease wise) & Key Players Analysis.
Adult Vaccines in the Report have been studied from 3 Viewpoints
Global Adult Vaccines (Disease wise) Market & Forecast (2011 – 2022)
People Immunized (Disease wise) & Forecast (2011 – 2022)
Doses of Vaccines Administered (Disease wise) & Forecast (2011 – 2022)
Vaccines Studied in the Report are as Follows:
Influenza
Cervical Cancer
Zoster (Shingles)
MMRV (Measles, Mumps, Rubella and Varicella)
Pneumonia
Meningitis
Hepatitis
DTap (Diphtheria, Tetanus, Pertussis)
Travel & Miscellaneous Vaccine
Companies Vaccines Sales and Forecast
Place an Enquiry to Our Industry Expert @ https://www.researchmoz.us/enquiry.php?type=E&repid=1237587
GlaxoSmithKline, plc Sales & Forecast (2011 – 2022)
Merck & Co. Sales & Forecast (2011 – 2022)
Sanofi Pasteur’s Sales & Forecast (2011 – 2022)
Pfizer, Inc.’s Sales & Forecast (2011 – 2022)
Others Vaccines
List of Table
Table 2-1: Vaccine Recommendations
Table 2-2: Other Recommended Vaccines
Table 3-1: Worldwide – Adult Vaccines Market Share (Percent), 2011 - 2016
Table 3-2: Worldwide – Adult Vaccines Market Share (Percent), 2017 - 2022
Table 5-1: Worldwide – Adult Immunized Share (Percent), 2011 - 2016
Table 5-2: Worldwide – Forecast for Adult Immunized Share (Percent), 2017 – 2022
Table 7-1: Worldwide – Doses of Vaccines Administered to Adult Share (Percent), 2011 - 2016
Table 7-2: Worldwide – Forecast for Doses of Vaccines Administered to Adult Share (Percent), 2017 - 2022
Table 12-1: Worldwide – Number of Reported Cases, 2011 – 2015
Table 12-2: Measles – Number of Cases Reported, 2001 – 2015
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us ;
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow us on Blogger at : https://marketreportandanalysis.blogspot.com
Adult Vaccines Market is expected to be close to US$ 20 Billion by the year 2022. Because of vaccines, some diseases (like Polio and Diphtheria) are becoming rare. Vaccination can prevent certain deadly diseases in all age groups. Almost all countries around the world have introduced efficient National Immunization Programme in their vaccination schedule to overcome the epidemics caused by vaccine-preventable diseases. WHO’s Global Vaccine Action Plan, Global Immunization Vision and Strategy (GIVS), The GAVI Alliance all are putting their best to minimize the incidence of vaccine-preventable diseases which indeed is driving the adult vaccine market vigorously.
For more info, Get Free PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=1237587
Influenza Vaccine Leads the Adult Vaccine Market for the Year 2017
Influenza vaccine is dominating the adult vaccine segment in year 2017, however it will lose its place to Pneumococcal vaccine in the coming future as admissions for pneumonia had almost tripled over the last 15 years. Other than Influenza and Pneumococcal Vaccines, Cervical Cancer (HPV), Hepatitis and Travel vaccines also have considerable market share in adult vaccines market.
Considerable Growth in Immunization of Cervical Cancer (HPV), Zoster, Meningococcal, Hepatitis, Tdap and MMRV Vaccines
In terms of Immunization; Influenza holds the maximum share as influenza vaccination is recommended to take annually in almost all countries of the world. However, with the growing awareness and efficiency of vaccines in preventing diseases, our analysis found that there will be considerably growth in the number for people opting for Cervical Cancer (HPV), Zoster, Meningococcal, Hepatitis, Tdap and MMRV vaccines in future till 2022.
Administration of Vaccines Doses
Influenza Vaccine holds the topmost place while talking about the administration of vaccine doses as influenza strains change every year and people needs to get an updated influenza shot each year to stay protected. Expect Influenza; Cervical Cancer (HPV), Pneumococcal and Hepatitis vaccines have remarkable administration doses.
Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis is the 2nd publication by Renub Research on Adult Vaccines Market. This 181 pages research report with 77 Figures and 32 Tables provides a complete analysis of Adult Vaccines Market, Immunization Numbers in People, Number of Vaccine Doses Administered in Adults (Disease wise) & Key Players Analysis.
Adult Vaccines in the Report have been studied from 3 Viewpoints
Global Adult Vaccines (Disease wise) Market & Forecast (2011 – 2022)
People Immunized (Disease wise) & Forecast (2011 – 2022)
Doses of Vaccines Administered (Disease wise) & Forecast (2011 – 2022)
Vaccines Studied in the Report are as Follows:
Influenza
Cervical Cancer
Zoster (Shingles)
MMRV (Measles, Mumps, Rubella and Varicella)
Pneumonia
Meningitis
Hepatitis
DTap (Diphtheria, Tetanus, Pertussis)
Travel & Miscellaneous Vaccine
Companies Vaccines Sales and Forecast
Place an Enquiry to Our Industry Expert @ https://www.researchmoz.us/enquiry.php?type=E&repid=1237587
GlaxoSmithKline, plc Sales & Forecast (2011 – 2022)
Merck & Co. Sales & Forecast (2011 – 2022)
Sanofi Pasteur’s Sales & Forecast (2011 – 2022)
Pfizer, Inc.’s Sales & Forecast (2011 – 2022)
Others Vaccines
List of Table
Table 2-1: Vaccine Recommendations
Table 2-2: Other Recommended Vaccines
Table 3-1: Worldwide – Adult Vaccines Market Share (Percent), 2011 - 2016
Table 3-2: Worldwide – Adult Vaccines Market Share (Percent), 2017 - 2022
Table 5-1: Worldwide – Adult Immunized Share (Percent), 2011 - 2016
Table 5-2: Worldwide – Forecast for Adult Immunized Share (Percent), 2017 – 2022
Table 7-1: Worldwide – Doses of Vaccines Administered to Adult Share (Percent), 2011 - 2016
Table 7-2: Worldwide – Forecast for Doses of Vaccines Administered to Adult Share (Percent), 2017 - 2022
Table 12-1: Worldwide – Number of Reported Cases, 2011 – 2015
Table 12-2: Measles – Number of Cases Reported, 2001 – 2015
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us ;
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow us on Blogger at : https://marketreportandanalysis.blogspot.com
No comments:
Post a Comment